Epigenetic Mechanism Links NMDA Receptor Hypofunction and Cognitive Deficits in Schizophrenia to D2 Receptors Comment

被引：4
|
作者：
Jackson, Michael F. [1 ,2 ]
机构：
[1] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada
[2] Kleysen Inst Adv Med, Neurosci Res Program, Hlth Sci Ctr, SR426,710 William Ave, Winnipeg, MB R3E 0Z3, Canada
来源：
BIOLOGICAL PSYCHIATRY | 2020年 / 87卷 / 08期
基金：
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词：
INHIBITION; DOPAMINE; COMPLEX;
D O I：
10.1016/j.biopsych.2020.01.024
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：692 / 694
页数：3
相关论文
共 50 条
  • [21] The role of extrastriatal dopamine D2 receptors in schizophrenia
    Takahashi, Hidehiko
    Higuchi, Makoto
    Suhara, Tetsuya
    BIOLOGICAL PSYCHIATRY, 2006, 59 (10) : 919 - 928
  • [22] Schizophrenia:: More dopamine, more D2 receptors
    Seeman, P
    Kapur, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) : 7673 - 7675
  • [23] Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia
    Pei, Ju-Chun
    Hung, Wei-Li
    Lin, Bei-Xuan
    Shih, Min-Han
    Lu, Liang-Yin
    Luo, Da-Zhong
    Tai, Hwan-Ching
    Studer, Vincent
    Min, Ming-Yuan
    Lai, Wen-Sung
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (10) : 1288 - 1302
  • [24] Effects of NMDA receptor antagonists on the binding of agonistic and antagonistic radiotracers to striatal dopamine D2 receptors
    Tokunaga, Masaki
    Maeda, Jun
    Seki, Chie
    Finnema, Sjoerd J.
    Zhang, Ming-Rong
    Fukumura, Toshimitsu
    Ito, Hiroshi
    Halldin, Christer
    Suhara, Tetsuya
    Higuchi, Makoto
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 : S57 - S58
  • [25] NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors—implications for models of schizophrenia
    S Kapur
    P Seeman
    Molecular Psychiatry, 2002, 7 : 837 - 844
  • [26] NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors -: implications for models of schizophrenia
    Kapur, S
    Seeman, P
    MOLECULAR PSYCHIATRY, 2002, 7 (08) : 837 - 844
  • [27] Dopamine D2 and Adenosine A2A Receptors Regulate NMDA-Mediated Excitation in Accumbens Neurons Through A2A–D2 Receptor Heteromerization
    Karima Azdad
    David Gall
    Amina S Woods
    Catherine Ledent
    Sergi Ferré
    Serge N Schiffmann
    Neuropsychopharmacology, 2009, 34 : 972 - 986
  • [28] DOPAMINE D2 RECEPTOR MOLECULAR VARIANT AND SCHIZOPHRENIA
    NOTHEN, MM
    WILDENAUER, D
    CICHON, S
    ALBUS, M
    MAIER, W
    MINGES, J
    LICHTERMANN, D
    BONDY, B
    RIETSCHEL, M
    KORNER, J
    FIMMERS, P
    PROPPING, P
    LANCET, 1994, 343 (8908): : 1301 - 1302
  • [29] Deletion of the Mitochondrial Matrix Protein Cydophilin D Prevents Parvalbumin Interneuron Dysfunction and Cognitive Deficits in a Mouse Model of NMDA Hypofunction
    Phensy, Aarron
    Lindquist, Kathy L.
    Lindquist, Karen A.
    Bairuty, Dania
    Gauba, Esha
    Guo, Lan
    Tian, Jing
    Du, Heng
    Kroener, Sven
    JOURNAL OF NEUROSCIENCE, 2020, 40 (32): : 6121 - 6132
  • [30] Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
    Abi-Dargham, A
    Rodenhiser, J
    Printz, D
    Zea-Ponce, Y
    Gil, R
    Kegeles, LS
    Weiss, R
    Cooper, TB
    Mann, JJ
    Van Heertum, RL
    Gorman, JM
    Laruelle, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) : 8104 - 8109
12345